ANDA 75292, held by Solis Pharms. Fluoxetine Hydrochloride.
As of Nov 16, 2026, ANDA 75292 (Fluoxetine Hydrochloride), held by Solis Pharms, was first approved by FDA on Feb 7, 2002, with 16 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 7, 2002 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fluoxetine HydrochlorideEQ 20MG BASE/5ML · solution;oral | Fluoxetine Hydrochloride | Rx |
| Aug 18, 2023 | Supplement 24Labeling · Standard review | Approved | None posted |
| Aug 9, 2023 | Supplement 23Labeling · Standard review | Approved | None posted |
| Sep 20, 2021 | Supplement 21Labeling · Standard review | Approved | None posted |
| Sep 12, 2021 | Supplement 20Labeling · Standard review | Approved | None posted |
| Jan 4, 2017 | Supplement 19Labeling · Standard review | Approved | None posted |
| Sep 2, 2014 | Supplement 18Labeling · Standard review | Approved | None posted |
| May 29, 2012 | Supplement 17Labeling | Approved | None posted |
| Dec 2, 2008 | Supplement 15Labeling | Approved | None posted |
| Jun 29, 2007 | Supplement 12Labeling | Approved | None posted |
| Jun 29, 2007 | Supplement 11Labeling | Approved | None posted |
| Aug 29, 2006 | Supplement 10Labeling | Approved | None posted |
| Aug 29, 2006 | Supplement 9Labeling | Approved | None posted |
| Mar 15, 2006 | Supplement 7Labeling | Approved | None posted |
| May 17, 2005 | Supplement 5Labeling | Approved | None posted |
| May 17, 2005 | Supplement 4Labeling | Approved | None posted |
| Sep 3, 2002 | Supplement 1Manufacturing | Approved | None posted |
| Feb 7, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters